StockWatch
·

Indian Renewable Energy Development Agency Ltd

BSE: 544026

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
2.3K
+4.2%+14.0%
Expenditure
1.6K
-10.8%+20.3%
Net Profit
554.27
+64.2%+1.0%
OPM %
89.27%
+10.88pp-4.02pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00656.531.3K2.0K2.6KQ4 FY25Q1 FY26Q2 FY26Q3 FY26Q1 FY27Q2 FY27
Price Chart
Reports

IREDA Q2 FY27: PAT flat YoY at ₹552 Cr as Gensol-driven provisioning compresses margins

nbfc · renewable energy financing · margin compression

ResultsQ2 FY2719 Oct 20263 minFinancial Services

Margins Hold — Provisions Set the Tone

renewable energy · NII growth · net interest margin

Result previewQ2 FY2713 Oct 20263 minFinancial Services

IREDA Q1 FY27: PAT rebounds 37% YoY to ₹338.5 Cr but falls 31% QoQ as provisions double

nbfc lending · renewable energy financing · loan loss provisioning

ResultsQ1 FY2703 Aug 20263 minFinancial Services
Latest
Board Meeting19 Oct, 7:30 pm

IREDA Q2 FY27: PAT flat YoY at ₹552 Cr as Gensol-driven provisioning compresses margins

IREDA's consolidated total income rose 14.0% YoY to ₹2,346.88 Cr (standalone ₹2,344.75 Cr, basis differs <0.4%), but consolidated PAT of ₹552.14 Cr was essentially flat YoY (+0.5% vs ₹549.33 Cr) — a sharp deceleration from the 14% revenue growth. The QoQ jump (+63.1% from Q1 FY27's ₹338.53 Cr) looks dramatic but is mean-reversion off a weak prior quarter rather than a trend acceleration; EPS at ₹1.97 is unchanged from a year ago on a flat equity base (₹2,809.23 Cr paid-up capital), confirming profit growth, not just share-count dilution, stalled. The story is margin compression on the lending book, not the topline. Net profit margin fell to 23.53% from 26.69% a year ago, and operating margin (total income less non-finance operating costs, our methodology) eased to roughly 88.7% from 93.29% YoY — though it did recover from Q1 FY27's 78.41%. Finance cost grew roughly in line with revenue (+13.6% YoY to ₹1,377.27 Cr), but impairment on financial instruments more than doubled to ₹187.70 Cr from ₹69.92 Cr YoY, the primary drag on profit growth. That impairment build coincides with the Stage-III provisioning coverage ratio rising sharply to 70.44% from 51.48% YoY, even as the net NPA ratio actually improved to 1.08% from 1.97% — a deliberately conservative provisioning stance rather than a deterioration in underlying asset quality. The provisioning build ties directly to this quarter's governance developments: at its 39th AGM on September 29, 2026 (within this reporting period per the event record), IREDA's board actions around the Gensol Engineering exposure (₹672.74 Cr, alongside a smaller Arjuna Biofuels case) drove the fraud reporting to RBI noted in both standalone and consolidated statements, with 100% ECL already provided. Management gives no formal quarterly guidance on record, and no press release commentary was available to cross-check against the print, so neither can be graded here. No Q2 FY27-specific consensus PAT estimate turned up in search; ICICI Direct's FY27E consolidated PAT estimate of ₹2,192 Cr (set ahead of Q1 FY27) implies H1 FY27's actual ₹890.67 Cr covers ~40.6% of the full-year number, meaning H2 needs to carry a larger share than usual — directionally consistent with a quarter that undershot normal profit cadence rather than beat it. Other period developments — the CMD's additional charge extension by three months (Oct 1) and the appointment of Shiv & Associates and MAPSS & Co. as joint statutory auditors for FY27 (Sep 25) — are procedural and don't bear on the numbers. The FY27 Performance MoU signed with MNRE (Oct 5) sets forward targets but was not available in enough detail to benchmark against this quarter's print.

19 Oct 2026, 07:30 pm

Corporate Events

Board MeetingIREDA
2026
30Oct

Board Meeting

The Board of Directors approved the appointment of Shri Jati…

BSE Filing ↗
Board MeetingIREDA
2026
19Oct

Board Meeting

The Board of Directors will consider and approve the audited…

BSE Filing ↗
Board MeetingIREDA
2026
29Sep

Board Meeting

The 39th Annual General Meeting ('AGM') of the members of th…

BSE Filing ↗
DividendIREDA
2026
11Sep

₹0.75 / share

BSE Filing ↗
Board MeetingIREDA
2026
22Aug

Board Meeting

The Board of Directors accorded approval for changes in the …

BSE Filing ↗
Board MeetingIREDA
2026
3Aug

Board Meeting

To consider and approve the unaudited financial results (Sta…

BSE Filing ↗
Board MeetingIREDA
2026
24Jul

Board Meeting

The Board of Directors of Indian Renewable Energy Developmen…

BSE Filing ↗
Board MeetingIREDA
2026
29May

Board Meeting

The board meeting is scheduled to consider and approve the a…

BSE Filing ↗
DividendIREDA
2026
2Apr

₹0.6 / share

BSE Filing ↗
Board MeetingIREDA
2026
25Mar

Board Meeting

To consider the proposal for declaration of Interim Dividend…

BSE Filing ↗
Board MeetingIREDA
2026
19Mar

Board Meeting

To consider enhancement of borrowing plan for FY 2025-26 and…

BSE Filing ↗
Board MeetingIREDA
2026
2Mar

Board Meeting

Board meeting held to designate a new Key Managerial Personn…

BSE Filing ↗
Board MeetingIREDA
2025
25Mar

Board Meeting

Consider and approve

BSE Filing ↗
Board MeetingIREDA
2025
23Jan

Board Meeting

Raising of funds through the issuance of equity shares by wa…

BSE Filing ↗
Board MeetingIREDA
2024
29Aug

Board Meeting

Consider And Approve The Proposal For Raising Of Funds By Wa…

BSE Filing ↗